SKI Market

Indian Indices

Sensex

78,918.90 -1,097.00
( -1.37%)

Global Indices

Nasdaq

47,518.20 -457.55
(-0.95%)

Dow Jones

6,761.35 -90.36
(-1.32%)

Hang Seng

55,600.46 322.40
(0.58%)

Nikkei 225

10,286.75 -127.19
(-1.22%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Solara Active Pharma Sciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541540

INE624Z01016

345.196547

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SOLARA

2015.05

EPS(TTM)

Face Value()

Div & Yield %

Back

B C C Fuba India standalone net profit rises 57.61% in the September 2025 quarter

Nov 13,2025

Net profit of B C C Fuba India rose 57.61% to Rs 1.45 crore in the quarter ended September 2025 as against Rs 0.92 crore during the previous quarter ended September 2024. Sales rose 50.40% to Rs 17.01 crore in the quarter ended September 2025 as against Rs 11.31 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	17.01	11.31	50
OPM %	15.46	12.82	-
PBDT	2.41	1.35	79
PBT	2.05	1.13	81
NP	1.45	0.92	58

78,918.90 -1,097.00 ( -1.37%)

47,518.20 -457.55 (-0.95%)

6,761.35 -90.36 (-1.32%)

55,600.46 322.40 (0.58%)

10,286.75 -127.19 (-1.22%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)